Literature DB >> 26739140

The neuroimaging of Leigh syndrome: case series and review of the literature.

Eliana Bonfante1, Mary Kay Koenig2, Rahmat B Adejumo3, Vinu Perinjelil3, Roy F Riascos4.   

Abstract

Leigh syndrome by definition is (1) a neurodegenerative disease with variable symptoms, (2) caused by mitochondrial dysfunction from a hereditary genetic defect and (3) accompanied by bilateral central nervous system lesions. A genetic etiology is confirmed in approximately 50% of patients, with more than 60 identified mutations in the nuclear and mitochondrial genomes. Here we review the clinical features and imaging studies of Leigh syndrome and describe the neuroimaging findings in a cohort of 17 children with genetically confirmed Leigh syndrome. MR findings include lesions in the brainstem in 9 children (53%), basal ganglia in 13 (76%), thalami in 4 (24%) and dentate nuclei in 2 (12%), and global atrophy in 2 (12%). The brainstem lesions were most frequent in the midbrain and medulla oblongata. With follow-up an increased number of lesions from baseline was observed in 7 of 13 children, evolution of the initial lesion was seen in 6, and complete regression of the lesions was seen in 3. No cerebral white matter lesions were found in any of the 17 children. In concordance with the literature, we found that Leigh syndrome follows a similar pattern of bilateral, symmetrical basal ganglia or brainstem changes. Lesions in Leigh syndrome evolve over time and a lack of visible lesions does not exclude the diagnosis. Reversibility of lesions is seen in some patients, making the continued search for treatment and prevention a priority for clinicians and researchers.

Entities:  

Keywords:  Basal ganglia; Brainstem; Children; Leigh syndrome; Magnetic resonance imaging; Mitochondrial disease; Necrotizing demyelination

Mesh:

Year:  2016        PMID: 26739140     DOI: 10.1007/s00247-015-3523-5

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  50 in total

1.  Genetic heterogeneity in Leigh syndrome.

Authors:  S DiMauro; D C De Vivo
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

2.  Leigh syndrome: MRI findings in two children.

Authors:  Al Kartikasalwah; Ngu Lh
Journal:  Biomed Imaging Interv J       Date:  2010-01-01

Review 3.  OXPHOS mutations and neurodegeneration.

Authors:  Werner J H Koopman; Felix Distelmaier; Jan A M Smeitink; Peter H G M Willems
Journal:  EMBO J       Date:  2012-11-13       Impact factor: 11.598

4.  Disturbed oxidative metabolism in subacute necrotizing encephalomyelopathy (Leigh syndrome).

Authors:  P M van Erven; W Ruitenbeek; F J Gabreëls; W O Renier; J C Fischer; A J Janssen
Journal:  Neuropediatrics       Date:  1986-02       Impact factor: 1.947

5.  MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations.

Authors:  Laura Farina; Luisa Chiapparini; Graziella Uziel; Marianna Bugiani; Massimo Zeviani; Mario Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

6.  Subacute necrotizing encephalomyelopathy of infancy and childhood.

Authors:  D Yashon; J A Jane
Journal:  J Clin Pathol       Date:  1967-01       Impact factor: 3.411

7.  Mechanisms of unexpected death and autopsy findings in Leigh syndrome (subacute necrotising encephalomyelopathy).

Authors:  Regula Wick; Grace Scott; Roger W Byard
Journal:  J Forensic Leg Med       Date:  2006-02-20       Impact factor: 1.614

Review 8.  Mitochondrial encephalopathy.

Authors:  Nicola Longo
Journal:  Neurol Clin       Date:  2003-11       Impact factor: 3.806

Review 9.  Late-onset Leigh syndrome in a patient with mitochondrial complex I NDUFS8 mutations.

Authors:  Vincent Procaccio; Douglas C Wallace
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

10.  de Toni-Fanconi-Debré syndrome with Leigh syndrome revealing severe muscle cytochrome c oxidase deficiency.

Authors:  H Ogier; A Lombes; H R Scholte; B T Poll-The; M Fardeau; J Alcardi; B Vignes; P Niaudet; J M Saudubray
Journal:  J Pediatr       Date:  1988-05       Impact factor: 4.406

View more
  18 in total

Review 1.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

Review 2.  Neuromitochondrial Disorders : Genomic Basis and an Algorithmic Approach to Imaging Diagnostics.

Authors:  Santhakumar Senthilvelan; Sabarish S Sekar; Chandrasekharan Kesavadas; Bejoy Thomas
Journal:  Clin Neuroradiol       Date:  2021-06-09       Impact factor: 3.649

Review 3.  The many faces of paediatric mitochondrial disease on neuroimaging.

Authors:  Fabian Baertling; Dirk Klee; Tobias B Haack; Holger Prokisch; Thomas Meitinger; Ertan Mayatepek; Jörg Schaper; Felix Distelmaier
Journal:  Childs Nerv Syst       Date:  2016-07-23       Impact factor: 1.475

4.  Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.

Authors:  Michele Ferrari; Isha H Jain; Olga Goldberger; Emanuele Rezoagli; Robrecht Thoonen; Kai-Hung Cheng; David E Sosnovik; Marielle Scherrer-Crosbie; Vamsi K Mootha; Warren M Zapol
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

5.  Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.

Authors:  Ria de Haas; Devashish Das; Alejandro Garanto; Herma G Renkema; Rick Greupink; Petra van den Broek; Jeanne Pertijs; Rob W J Collin; Peter Willems; Julien Beyrath; Arend Heerschap; Frans G Russel; Jan A Smeitink
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

6.  Novel NDUFA13 Mutations Associated with OXPHOS Deficiency and Leigh Syndrome: A Second Family Report.

Authors:  Adrián González-Quintana; Inés García-Consuegra; Amaya Belanger-Quintana; Pablo Serrano-Lorenzo; Alejandro Lucia; Alberto Blázquez; Jorge Docampo; Cristina Ugalde; María Morán; Joaquín Arenas; Miguel A Martín
Journal:  Genes (Basel)       Date:  2020-07-26       Impact factor: 4.096

7.  Clinical, Neuroimaging, and Pathological Analyses of 13 Chinese Leigh Syndrome Patients with Mitochondrial DNA Mutations.

Authors:  Xiao-Lin Yu; Chuan-Zhu Yan; Kun-Qian Ji; Peng-Fei Lin; Xue-Bi Xu; Ting-Jun Dai; Wei Li; Yu-Ying Zhao
Journal:  Chin Med J (Engl)       Date:  2018-11-20       Impact factor: 2.628

8.  Mitochondrial Disease: Advances in clinical diagnosis, management, therapeutic development, and preventative strategies.

Authors:  Colleen C Muraresku; Elizabeth M McCormick; Marni J Falk
Journal:  Curr Genet Med Rep       Date:  2018-05-02

9.  Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease.

Authors:  Simon C Johnson; Ernst-Bernhard Kayser; Rebecca Bornstein; Julia Stokes; Alessandro Bitto; Kyung Yeon Park; Amanda Pan; Grace Sun; Daniel Raftery; Matt Kaeberlein; Margaret M Sedensky; Philip G Morgan
Journal:  Mol Genet Metab       Date:  2020-04-03       Impact factor: 4.204

10.  LEIGH SYNDROME: A CASE REPORT WITH A MITOCHONDRIAL DNA MUTATION.

Authors:  Tânia Lopes; Margarida Coelho; Diana Bordalo; António Bandeira; Anabela Bandeira; Laura Vilarinho; Paula Fonseca; Sónia Carvalho; Cecília Martins; José Gonçalves Oliveira
Journal:  Rev Paul Pediatr       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.